| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 18.72× | 18.72× | 20.18× | 23.48× | 27.45× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.66× | 1.61× | 1.38× | 1.42× | 1.13× | ||
| 0.50× | 0.50× | 0.55× | 0.50× | 0.40× | ||
| 1.03× | 1.03× | 1.03× | 0.92× | 0.90× | ||
| 0.80× | 0.80× | 0.87× | 0.79× | 0.77× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 27.45 | 23.48 | 20.18 | 18.72 | 18.72 | |
| Working Capital Turnover | 1.13 | 1.42 | 1.38 | 1.61 | 1.66 | |
| Asset Turnover | 0.40 | 0.50 | 0.55 | 0.50 | 0.50 | |
| Cash Conversion (CFO/Net Income) | 0.90 | 0.92 | 1.03 | 1.03 | 1.03 | |
| CFO/EBITDA | 0.77 | 0.79 | 0.87 | 0.80 | 0.80 |